UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/200/0.01/18.06.25 Share Price

Warrant

9620T

DE000HC9YG50

Real-time Euronext Paris 17:30:01 16/07/2024 BST
0.19 EUR -9.52% Intraday chart for UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/200/0.01/18.06.25
Current month+5.56%
1 month-36.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
16/07/24 0.19 -9.52%
15/07/24 0.21 0.00%
12/07/24 0.21 0.00%
11/07/24 0.21 +16.67%
10/07/24 0.18 +5.88%

Real-time Euronext Paris

Last update July 16, 2024 at 05:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer UniCredit UniCredit
9620T
ISINDE000HC9YG50
Date issued 16/10/2023
Strike 200
Maturity 18/06/2025 (336 Days)
Parity 100 : 1
Emission price-
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.05
Lowest since issue 0.12
Delta0.47x
Omega 3.715
Premium30.18x
Gearing7.91x
Moneyness 0.8508
Difference Strike 27.8
Difference Strike %+13.90%
Spread 0.05
Spread %20.83%
Theoretical value 0.2150
Implied Volatility 46.57 %
Total Loss Probability 69.83 %
Intrinsic value 0.000000
Present value 0.2150
Break even 221.50 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
170.2 EUR
Average target price
237.3 EUR
Spread / Average Target
+39.48%
Consensus
  1. Stock Market
  2. Warrants
  3. 9620T Warrant